Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Feb 16, 2018 12:38pm
347 Views
Post# 27573069

RE:RE:RBC report on MOA

RE:RE:RBC report on MOA
I just sent the same comments to our private email group Scott.  Completely agree.

ITs going to take a while for this to truly permeate, and for all relevant players to grasp the magnitude.

I think the KOL meeting of a couple of weeks ago, along with this MOA and the Allstrom Data we are expecting will collectively prove to be THE fundamental turning point of sentiment and confidence in the small molecule program.

As you know all too well from your disucssions with them....,  Pierre, Dr Moran, Dr Gagnon etc have been pounding the table for two years about this discovery and how relevant it is... and what it really means.... all while they mad scrambled in the background to patent almost every outcome.

  It obviously takes time for crediblity to be built around huge discoveries like this,  particularly when they are disruptive and novel..... It first gets reviewed and gets traction in the peer review process of the scientific community and then ultimately translates to industry and the capital markets... although not necessarilly in that order.

 Canadian analysts that follow this company ( outside of Doug Cooper ) have constantly referred to 4050 and analogues as a lottery ticket on top of th PPPS fundamental value driver .   I am of the opinion that everyone is finally waking up to the prospect that this small molecule program is ALOT more than that.....  and most importantly Wall street is on the verge of busting this wide open as they begin to believe these guys have discovered one of THE keys to reversing Fibrosis and Fibrotic related condiitions.

We know for a fact that PLI is in advanced discussions with the largest prospective strategic partners.....  and EXACTLY when NOBODY believes a deal is going to get done,  we will be waking up to a headline that will shock everyone and will fundamentally revalue this company much much higher.

Cant say whether that happens before or after a Nasdaq list,  but its coming in short order and its a game changer.

As an aside,   its just remarkable to see the trolls spawning one after one out of the woodwork as the likelihood of a positive outcome becomes by far the highest probability.   Guys are showing up with 100's of ignores having never posted here before.    Coincidence that the US short position dropped nearly 20% in the last two week reported period....  and that they are collectivley using this perpetual negative drumbeat to  prey on the weary .   it just boggles my mind the lengths that these guys go to with their short agenda.....  like a WWII leaflet propoganda campaign.   No question whatsoever that PLI mgmt has helped facilitate this thru the bumbling... but the science breakthrough will rule the day.

Tecnically,  the 50 day MAV is upsloping and about to intersect the 200 day MAV on the one year chart.... this will be the final bottom signal.
Bullboard Posts